Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors. 2019

Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
Zhengzhou Children's Hospital, ZZ 450018, China; State Key Laboratory of Pharmaceutical Biotechnology, NJ 210023, China.

For the purpose of synthesizing drug candidates with desirable bioactivity, a class of benzoyl amide containing nitrogen heterocyclic ring derivatives targeting VEGFR-2 was designed and screened out using Discovery Studio. Eighteen target compounds were synthesized and then selected by some biological trials sequentially including inhibition of VEGFR-2, anti-proliferation in vitro, flow cytometry. Among them, compound 8h showed the best inhibitory activity (IC50 = 0.34 ± 0.02 μM against VEGFR-2, IC50 = 1.08 ± 0.06 μM and 2.44 ± 0.15 μM against MCF-7 and HepG-2, respectively, which were at the same inhibitory level with the commercially antitumor drug: vandetanib). In addition, flow cytometry demonstrated that compound 8h induced MCF-7 cell apoptosis through a cell membrane-mediated pathway. This research highlights the therapeutic potential of novel VEGFR-2 inhibitors in treating cancers and provides a promising strategy for drug discovery.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
November 2010, Bioorganic & medicinal chemistry letters,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
November 2012, Bioorganic & medicinal chemistry,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
January 2018, Current pharmaceutical design,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
August 2018, Bioorganic chemistry,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
January 2014, Bioorganic & medicinal chemistry,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
November 2022, Future medicinal chemistry,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
August 2016, Molecules (Basel, Switzerland),
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
August 2018, Bioorganic & medicinal chemistry letters,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
April 2015, European journal of medicinal chemistry,
Fa-Qian Shen, and Lu Shi, and Ze-Feng Wang, and Chen-Ru Wang, and Jin-Jin Chen, and Yi Liu, and Han-Yue Qiu, and Hai-Liang Zhu
November 2019, Archiv der Pharmazie,
Copied contents to your clipboard!